Linked Patient Learning

Loading Experience

Whether you're struggling to take your meds, building patient programs for your pharma company, or just trying to help a loved one—here's what's actually working in 2025.
Your mom just got home from the hospital after a heart attack. Five new prescriptions. One costs $1,500 a month. Instructions are confusing. Side effects suck. Three months later? Pills still sitting in the cabinet, mostly full.
One in four Americans can't afford their medications, and about half don't take them correctly. Result: 100,000 preventable deaths yearly and $100 billion wastedMagellanhealthinsights.
Why "just take your medicine" doesn't work:
It costs $200 and you have $87
The pills make you feel worse
You're taking 8 different pills at 4 different times
You feel fine now, so... problem solved?
You legitimately forgot
Most adherence programs send you the 47th reminder notification. As if that'll be the magical one.
The Real Cost:
$300Bwasted annually
100,000preventable deaths/year
10-30xhigher death risk than homicide
50%of meds taken incorrectly
Why Now?
For decades we've known adherence is a crisis. We're not saying it's solved—but we're finally seeing real progress.
Behavioral economics is being implemented at scale.AI is mature enough for true personalization. COVID accelerated digital health by 5+ years. Cost transparency is forcing new models. The tools are starting to match the complexity of human behavior.
What's Moving the Needle
WellthWellthapp.
AllazoHealthBusiness Wire. For heart disease, that's thousands of lives.
Cost Plus DrugsDeloitte Insights. When meds cost $12 instead of $120, adherence gets simpler.
MedisafeMedisafe. People will change behavior for a $10 Starbucks card.
The Pre-Adherence Problem
Here's what most companies miss:adherence doesn't matter if patients never start treatment.
These consumer tools work for patients already taking medications. But for specialty and rare disease pharma, the biggest problem happens earlier:
❌ Patients don't recognize treatable symptoms❌ 2+ years from symptom → diagnosis → treatment❌ Patient support overwhelmed with calls❌ Low treatment starts, worse adherence
This is whereLinked Patient Learningchanges the game.
We accelerate patient engagement for specialty/rare disease brands through AI and digital-integrated education platforms built for your specific ecosystem.
What we solve:
Patients/caregivers recognizing symptoms are treatable
Shortening symptom → diagnosis → treatment timeline
Reducing patient support call volume
Increasing treatment starts and adherence
How:Connect the entire patient ecosystem with AI-powered education that guides from awareness → diagnosis → treatment start. Integrates directly with your consumer marketing and patient services.
Results:Faster diagnosis. More treatment starts. Better adherence.
The difference:They fix the problem upstream. By the time patients reach your medication, they're educated, prepared, and actually ready to start. The other platforms optimize adherence—Linked Patient Learning ensures patients get there in the first place.
The Bottom Line
Your risk of death from not taking meds is 10-30x higher than being murderedMagellanhealthinsights.
That $300 billion isn't abstract. It's your dad's readmission. Your mom's preventable stroke. Your neighbor who can't afford insulin.
We're not claiming the crisis is solved. But for the first time, we're seeing real progress—AI that predicts behavior, incentives that change habits, transparent pricing, and strategic interventions that happen before patients ever get a prescription.
These aren't silver bullets. But they're moving the needle in ways generic reminders never could.
The question is whether we'll scale what's working.
Take Action
Patients/caregivers:MedisafeGoodRxtoday. Share this with someone struggling.
Pharma/biopharma companies:Linked Patient LearningAllazoHealthWellthfor ongoing support.
Everyone:Stop pretending adherence is about willpower. It's about systems that work with human nature. Share this with someone who needs it.
Your mom still isn't taking her pills. But at least now we're making progress on solutions that might actually help.
Written by
Liza Prettypaul-Lodhia
Share your details and we'll send you the playbook.